Literature DB >> 17441790

Airway expression of calcitonin gene-related peptide in T-cell peptide-induced late asthmatic reactions in atopics.

A B Kay1, F R Ali, L G Heaney, F Benyahia, C P C Soh, H Renz, T H Lee, M Larché.   

Abstract

BACKGROUND: The mechanisms of late asthmatic reactions provoked in atopic asthmatics by allergen-derived T-cell peptide epitopes remain unclear. Previous studies showed no changes in airway eosinophils or mast cell products after peptide challenge. In the present study our aim was to measure calcitonin gene-related peptide (CGRP), neurokinin (NK)-A, and substance P (SP) in bronchoalveolar lavage fluid and bronchial biopsies (BB) after inhalation of allergen-derived T-cell peptide epitopes since these neuropeptides (NP) had not previously been evaluated in this chronic asthma model.
METHODS: Bronchoscopy, with BB and bronchoalveolar lavage (BAL), was performed in 24 cat-allergic subjects 6 h after inhalation of Fel d 1-derived peptides. Neuropeptides were measured in BAL by enzyme-linked immunosorbent assay and CGRP expression in the airways was assessed by immunohistochemistry and confocal microscopy.
RESULTS: Twelve subjects (termed 'responders') developed isolated late reactions. Calcitonin gene-related peptide, but not NK-A or SP, was significantly elevated in BAL in responders only. Biopsy studies showed that in virtually all responders peptide challenge induced marked increases in CGRP immunoreactivity in bronchial epithelial cells, infiltrating submucosal cells and in association with airway smooth muscle. Double immunostaining indicated that CGRP colocalized predominantly to CD3+/CD4+ and CD68+ submucosal inflammatory cells.
CONCLUSION: Calcitonin gene-related peptide, a potent vasodilator, is markedly up-regulated in the airways of atopic asthmatics during late-phase reactions provoked by inhalation of allergen-derived T-cell peptides.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17441790     DOI: 10.1111/j.1398-9995.2007.01342.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  12 in total

1.  Neuro-immune interactions in allergic diseases: novel targets for therapeutics.

Authors:  Tiphaine Voisin; Amélie Bouvier; Isaac M Chiu
Journal:  Int Immunol       Date:  2017-06-01       Impact factor: 4.823

Review 2.  Neuro-immune crosstalk and allergic inflammation.

Authors:  Hiroki Kabata; David Artis
Journal:  J Clin Invest       Date:  2019-03-04       Impact factor: 14.808

3.  Airway hyperresponsiveness and bronchial mucosal inflammation in T cell peptide-induced asthmatic reactions in atopic subjects.

Authors:  F Runa Ali; A Barry Kay; Mark Larché
Journal:  Thorax       Date:  2007-03-27       Impact factor: 9.139

Review 4.  The development of allergic inflammation.

Authors:  Stephen J Galli; Mindy Tsai; Adrian M Piliponsky
Journal:  Nature       Date:  2008-07-24       Impact factor: 49.962

Review 5.  Interactions of the immune and sensory nervous systems in atopy.

Authors:  Landon K Oetjen; Brian S Kim
Journal:  FEBS J       Date:  2018-04-30       Impact factor: 5.542

Review 6.  Neuroimmune Pathophysiology in Asthma.

Authors:  Gandhi F Pavón-Romero; Nancy Haydée Serrano-Pérez; Lizbeth García-Sánchez; Fernando Ramírez-Jiménez; Luis M Terán
Journal:  Front Cell Dev Biol       Date:  2021-05-13

Review 7.  Targeting chemokine receptors in disease--a case study of CCR4.

Authors:  Roberto Solari; James E Pease
Journal:  Eur J Pharmacol       Date:  2015-05-14       Impact factor: 4.432

8.  A TRPA1 inhibitor suppresses neurogenic inflammation and airway contraction for asthma treatment.

Authors:  Alessia Balestrini; Victory Joseph; Michelle Dourado; Rebecca M Reese; Shannon D Shields; Lionel Rougé; Daniel D Bravo; Tania Chernov-Rogan; Cary D Austin; Huifen Chen; Lan Wang; Elisia Villemure; Daniel G M Shore; Vishal A Verma; Baihua Hu; Yong Chen; Laurie Leong; Chris Bjornson; Kathy Hötzel; Alvin Gogineni; Wyne P Lee; Eric Suto; Xiumin Wu; John Liu; Juan Zhang; Vineela Gandham; Jianyong Wang; Jian Payandeh; Claudio Ciferri; Alberto Estevez; Christopher P Arthur; Jens Kortmann; Ryan L Wong; Jose E Heredia; Jonas Doerr; Min Jung; Jason A Vander Heiden; Merone Roose-Girma; Lucinda Tam; Kai H Barck; Richard A D Carano; Han Ting Ding; Bobby Brillantes; Christine Tam; Xiaoying Yang; Simon S Gao; Justin Q Ly; Liling Liu; Liuxi Chen; Bianca M Liederer; Joseph H Lin; Steven Magnuson; Jun Chen; David H Hackos; Justin Elstrott; Alexis Rohou; Brian S Safina; Matthew Volgraf; Rebecca N Bauer; Lorena Riol-Blanco
Journal:  J Exp Med       Date:  2021-04-05       Impact factor: 14.307

9.  Deficiency of RAMP1 attenuates antigen-induced airway hyperresponsiveness in mice.

Authors:  Manyu Li; Sarah E Wetzel-Strong; Xiaoyang Hua; Stephen L Tilley; Erin Oswald; Matthew F Krummel; Kathleen M Caron
Journal:  PLoS One       Date:  2014-07-10       Impact factor: 3.240

Review 10.  Neuropeptides in asthma, chronic obstructive pulmonary disease and cystic fibrosis.

Authors:  Kalina R Atanasova; Leah R Reznikov
Journal:  Respir Res       Date:  2018-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.